Internal dose to active marrow and endosteum from radioactive iodine.
暂无分享,去创建一个
[1] H. Miri-Hakimabad,et al. Internal dosimetry estimates using voxelized reference phantoms for thyroid agents , 2013, Journal of radiation research.
[2] A. Gardumi,et al. Evaluation of absorbed and effective doses to patients from radiopharmaceuticals using the ICRP 110 reference computational phantoms and ICRP 103 formulation. , 2013, Radiation protection dosimetry.
[3] Carlo Chiesa,et al. EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Stephen R. Thomas,et al. MIRD Pamphlet No. 21: A Generalized Schema for Radiopharmaceutical Dosimetry—Standardization of Nomenclature , 2009, Journal of Nuclear Medicine.
[5] W E Bolch,et al. Voxel-based models representing the male and female ICRP reference adult--the skeleton. , 2007, Radiation protection dosimetry.
[6] J. F. Briesmeister. MCNP-A General Monte Carlo N-Particle Transport Code , 1993 .
[7] V. R. McCready,et al. Radiation dose assessments in radioiodine (131I) therapy. 1. The necessity for in vivo quantitation and dosimetry in the treatment of carcinoma of the thyroid. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.